Home » BAYER SIGNS GENETIC TECHNOLOGY DEAL WITH UK FIRMS
BAYER SIGNS GENETIC TECHNOLOGY DEAL WITH UK FIRMS
Bayer HealthCare's diagnostics division has entered into an agreement with two British firms to develop a technology that could help predict the genetic likelihood of disease. Bayer HealthCare, a subsidiary of German drug and chemical maker Bayer, said it would also use the technology to develop tests that could better target the treatment of disease by matching it to a person's unique genetic make-up.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May